Clinical Focus


  • Pediatric Critical Care Medicine
  • Neurocritical Care

Academic Appointments


Administrative Appointments


  • Co-Director Pediatric Neurocritical care, Critical Care Medicine (2018 - Present)

Boards, Advisory Committees, Professional Organizations


  • Co-Chair, Professional Practice Evaluation Committee. Lucile Packard Children’s Hospital, Stanford University (2018 - Present)
  • Appointed Committee Member, Post Graduate and Fellowship Education Committee, Society of Critical Care Medicine (SCCM) (2017 - Present)
  • Member, Society of Critical Care Medicine (SCCM) (2013 - Present)
  • Member, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) (2016 - Present)
  • Member, Pediatric Neurocritical Care Research Group (PNCRG) (2016 - Present)
  • Member, Neurocritical Care Society (NCS) Pediatric Neurocritical Care Section (2018 - Present)
  • Member, Council on Child Abuse and Neglect (COCAN), American Academy of Pediatrics (2019 - Present)
  • Fellow, American Academy of Pediatrics (2017 - Present)

Professional Education


  • Medical Education:Medical College Of Wisconsin Office of Graduate Medical Education (2010) WI
  • Board Certification: Pediatric Critical Care Medicine, American Board of Pediatrics (2016)
  • Fellowship:Johns Hopkins University School of Medicine (2016) MD
  • Board Certification: Pediatrics, American Board of Pediatrics (2013)
  • Residency:Children's National Medical Center (2013) DC

Current Research and Scholarly Interests


My research interests reside in the field of Neurocritical Care Medicine. My research focus has included inflammation following traumatic brain injury, outcome prediction after cardiac arrest, and neuro-monitoring in the pediatric intensive care setting. These interests are integrated clinically to focus on the merging of specialized neurologic monitoring and care with prognostic efforts in critically ill patients.

All Publications


  • Infrastructure and Practice Characteristics of Pediatric ECMO Programs in the US and Canada Society of Critical Care Medicine Troy , L., Su, F., Berg, M., Rasmussen , L., Kuo, T., Jett, E., Jacobs, K., Haileselassie , B. 2019
  • Trauma Bay Disposition of Infants and Young Children With Mild Traumatic Brain Injury and Positive Head Imaging Pediatric Critical Care Medicine Noje, C., Jackson, E., Nasr, I., Costabile, P., Cerullo, M., Hoops, K., Rasmussen, L., Henderson, E., Ziegfeld, S., Puett, L., Robertson , C. 2019
  • A Case Series of Parechovirus Encephalopathy: Apnea and Autonomic Dysregulation in Critically Ill Infants JOURNAL OF CHILD NEUROLOGY Ristagno, E. H., Bhalla, S. C., Rasmussen, L. K. 2018; 33 (12): 788–93

    Abstract

    This article aims to describe a rare cause of severe encephalitis in 2 cases of infants with signs of intracranial hypertension and severe autonomic dysregulation. The authors conclude that human parechoviruses are becoming a more recognized cause of encephalitis because of the increasing use of rapid detection methods. With early recognition of this clinical entity, improved care can be administered.

    View details for DOI 10.1177/0883073818789317

    View details for Web of Science ID 000444976000007

    View details for PubMedID 30105932

  • Traumatic Injury Leads to Inflammation and Altered Tryptophan Metabolism in the Juvenile Rabbit Brain JOURNAL OF NEUROTRAUMA Zhang, Z., Rasmussen, L., Saraswati, M., Koehler, R. C., Robertson, C., Kannan, S. 2019; 36 (1): 74–86
  • Neurocritical Care for Severe Pediatric Traumatic Brain Injury Rasmussen, L., Raghupathi, R., Lang Chen , S., Huh, J., Su, F. Medscap Drugs and Diseases. 2018
  • Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection INTERNATIONAL JOURNAL OF PEDIATRICS Rasmussen, L. K., Schuette, J., Spaeder, M. C. 2016: 7021943

    Abstract

    Introduction. Human metapneumovirus (HMPV) is a paramyxovirus from the same subfamily as respiratory syncytial virus (RSV) and causes similar acute lower respiratory tract infection. Albuterol in the setting of acute RSV infection is controversial and has not yet been studied in HMPV. We sought to determine the frequency of albuterol use in HMPV infection and the association between albuterol administration and patient outcomes. Methods. We conducted a retrospective cohort study identifying all patients hospitalized in a tertiary care children's hospital with laboratory-confirmed HMPV infection between January 2010 and December 2010. Results. There were 207 patients included in the study; 57% had a chronic medical condition. The median hospital length of stay was 3 days. Only 31% of patients in the study had a documented wheezing history, while 69% of patients received at least one albuterol treatment. There was no difference in length of stay between patients who received albuterol and those who did not. Conclusion. There is a high frequency of albuterol use in children hospitalized with HMPV infection. As with RSV, evidence may not support routine use of bronchodilators in patients with acute HMPV respiratory infection. Research involving additional patient outcomes and illness severity indicators would be useful in future studies.

    View details for PubMedID 26925109

    View details for PubMedCentralID PMC4748140

  • PERIPHERAL IMMUNE RESPONSE AFTER PEDIATRIC TRAUMATIC BRAIN INJURY IN RABBIT Rasmussen, L., Zhang, Z., Saraswati, M., Kannan, S., Robertson, C. MARY ANN LIEBERT, INC. 2015: A88